Balixafortide CAS NO.1051366-32-5

We provide customized and high-quality Balixafortide product for your project.

Balixafortide is a potent and selective antagonist of the chemokine receptor CXCR4. The combination of balixafortide and eribulin was previously granted a fast track designation for the treatment of HER2-negative metastatic breast cancer in patients who have received at least 2 prior lines of chemotherapy in the metastatic setting by the FDA in 2018.